Your browser doesn't support javascript.
loading
Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[2,1-b]thiazole scaffold.
Abdel-Maksoud, Mohammed S; Ammar, Usama M; Oh, Chang-Hyun.
Afiliação
  • Abdel-Maksoud MS; Medicinal & Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre (NRC), Dokki, Giza 12622, Egypt.
  • Ammar UM; Center for Biomaterials, Korea Institute of Science & Technology (KIST School), Seoul, Seongbuk-gu 02792, Republic of Korea; University of Science & Technology (UST), Daejeon, Yuseong-gu 34113, Republic of Korea; Department of Biomolecular Science, University of Science & Technology (UST), Daejeon, Yuseong-gu 34113, Republic of Korea; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ahram Canadian University, Giza 12566, Egypt.
  • Oh CH; Center for Biomaterials, Korea Institute of Science & Technology (KIST School), Seoul, Seongbuk-gu 02792, Republic of Korea; University of Science & Technology (UST), Daejeon, Yuseong-gu 34113, Republic of Korea; Department of Biomolecular Science, University of Science & Technology (UST), Daejeon, Yuseong-gu 34113, Republic of Korea. Electronic address: choh@kist.re.kr.
Bioorg Med Chem ; 27(10): 2041-2051, 2019 05 15.
Article em En | MEDLINE | ID: mdl-30955995

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiazóis / Proteínas Proto-Oncogênicas B-raf / Inibidores de Proteínas Quinases / Imidazóis / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article